Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Thomas, Xavier  [Clear All Filters]
Journal Article
Michallet, M., Sobh, M., Serrier, C., Morisset, S., Labussière, H., Ducastelle, S., Barraco, F., Gilis, L., Thomas, X., and Nicolini, F.E. (2014). Allogeneic hematopoietic stem cell transplantation for hematological malignancies from mismatched 9/10 HLA unrelated donors: Comparison with transplantations from 10/10 unrelated donors and HLA identical siblings.Leuk Lymphoma1-16.
Thomas, X. (2014). Current indications of allogeneic stem cell transplant in adults with acute myeloid leukemia.Bull Cancer.
Bertoli, S., Paubelle, E., Bérard, E., Saland, E., Thomas, X., Tavitian, S., Larcher, M.-V., Vergez, F., Sarry, A., Huguet, F., et al. (2018). Ferritin heavy/light chain (FTH1/FTL) expression, serum ferritin levels and their functional as well as prognostic roles in acute myeloid leukemia.Eur J Haematol.
Baron, F., Efficace, F., Cannella, L., Muus, P., Trisolini, S., Halkes, C.J.M., Fazi, P., Vignetti, M., Marie, J.-P., Chiusolo, P., et al. (2020). Impact of the type of anthracycline and of stem cell transplantation in younger patients with acute myeloid leukaemia: long-term follow up of a phase III study.Am J Hematol.
Plesa, A., Chelghoum, Y., Mattei, E., Labussière, H., Elhamri, M., Cannas, G., Morisset, S., Tagoug, I., Michallet, M., Dumontet, C., et al. (2013). Mobilization of CD34(+)CD38(-) hematopoietic stem cells after priming in acute myeloid leukemia.World J Stem Cells5, 196-204.
Michallet, M., Sobh, M., Labussière, H., Lombard, C., Barraco, F., El-Hamri, M., Thomas, X., Chapuis-Cellier, C., and Nicolini, F.E. (2016). Potential anti-leukemic activity of iron chelation after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia.Leuk Lymphoma1-4.
Dhedin, N., Huynh, A., Maury, S., Tabrizi, R., Beldjord, K., Asnafi, V., Thomas, X., Chevallier, P., Nguyen, S., Coiteux, V., et al. (2015). Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia.Blood.
Jabbour, E.J., Gökbuget, N., Kantarjian, H.M., Thomas, X., Larson, R.A., Yoon, S.-S., Ghobadi, A., Topp, M.S., Tran, Q., Franklin, J.L., et al. (2019). Transplantation in adults with relapsed/refractory acute lymphoblastic leukemia who are treated with blinatumomab from a phase 3 study.Cancer.